These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34611210)

  • 1. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres.
    Depalo T; Traino AC; Bargellini I; Lorenzoni G; Bozzi E; Vivaldi C; Lamastra R; Masi G; Cioni R; Boni G; Volterrani D
    Sci Rep; 2021 Oct; 11(1):19745. PubMed ID: 34611210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma.
    Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT
    J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma.
    Mosconi C; Cappelli A; Ascanio S; Pettinari I; Modestino F; Renzulli M; Galaverni MC; Cucchetti A; Gramenzi A; Pettinato C; Golfieri R
    Future Oncol; 2017 Jun; 13(15):1301-1310. PubMed ID: 28343412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
    Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N
    Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1194-1203. PubMed ID: 33890170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
    Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
    Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
    Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
    Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
    J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging.
    Chang TT; Bourgeois AC; Balius AM; Pasciak AS
    J Vasc Interv Radiol; 2013 Mar; 24(3):333-7. PubMed ID: 23433408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Treatment with
    Filippi L; Di Costanzo GG; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O
    Cancer Biother Radiopharm; 2019 May; 34(4):231-237. PubMed ID: 30758985
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
    Gangi A; Shah J; Hatfield N; Smith J; Sweeney J; Choi J; El-Haddad G; Biebel B; Parikh N; Arslan B; Hoffe SE; Frakes JM; Springett GM; Anaya DA; Malafa M; Chen DT; Chen Y; Kim RD; Shridhar R; Kis B
    J Vasc Interv Radiol; 2018 Aug; 29(8):1101-1108. PubMed ID: 30042074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
    Saxena A; Bester L; Chua TC; Chu FC; Morris DL
    Ann Surg Oncol; 2010 Feb; 17(2):484-91. PubMed ID: 19876691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Soydal C; Kucuk ON; Bilgic S; Ibis E
    Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
    Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K
    Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.
    Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):481-489. PubMed ID: 27826686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
    Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
    Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis.
    Buettner S; Braat AJAT; Margonis GA; Brown DB; Taylor KB; Borgmann AJ; Kappadath SC; Mahvash A; IJzermans JNM; Weiss MJ; Lamarca A; Bell JK; Valle JW; Hagendoorn J; Koerkamp BG; Sze DY; Lam MGEH
    J Vasc Interv Radiol; 2020 Jul; 31(7):1035-1043.e2. PubMed ID: 32473757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
    Mouli S; Memon K; Baker T; Benson AB; Mulcahy MF; Gupta R; Ryu RK; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Aug; 24(8):1227-34. PubMed ID: 23602420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.